NorthRock Partners’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
28,817
-15
-0.1% -$198 0.01% 437
2026
Q1
$474K Sell
28,832
-44
-0.2% -$1.08K 0.01% 426
2025
Q4
$825K Sell
28,876
-41
-0.1% -$1.11K 0.01% 302
2025
Q3
$852K Sell
28,917
-1,560
-5% -$42.7K 0.02% 385
2025
Q2
$878K Buy
30,477
+1,188
+4% +$35.1K 0.02% 267
2025
Q1
$1.02M Sell
29,289
-313
-1% -$12.8K 0.03% 204
2024
Q4
$1.32M Buy
+29,602
New +$1.21M 0.04% 166

Other funds holding QDEL

NorthRock Partners's QDEL Position: Q2 2026 in Review

NorthRock Partners reduced its QuidelOrtho (QDEL) stake by 0.05% in Q2 2026, selling an estimated $198 and leaving 28,817 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #437.

NorthRock Partners first reported a position in QDEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q4 2024. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • NorthRock Partners held 28,817 shares of QuidelOrtho worth $505K as of Q2 2026.
  • NorthRock Partners sold 15 QuidelOrtho shares in Q2 2026, an estimated $198.
  • QuidelOrtho made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #437 holding.
  • NorthRock Partners first reported a position in QuidelOrtho in Q4 2024 and has held it in 7 quarters since.
  • NorthRock Partners's QuidelOrtho position peaked at $1.32M in Q4 2024.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.